title: Have we overcome choline PET/CT for early detection of prostate cancer recurrence?
authors.affiliation: aDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA bDepartment of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich cDepartment of Nuclear Medicine, Julius-Maximilians-University of Würzburg, Würzburg, Germany dDepartment of Nuclear Medicine, Santa Maria della Misericordia Rovigo Hospital, Rovigo, Italy.
authors.forename: Wolfgang P
authors.initials: WP
authors.lastname: Fendler
authors.forename: Christina
authors.initials: C
authors.lastname: Bluemel
authors.forename: Domenico
authors.initials: D
authors.lastname: Rubello
authors.forename: Ken
authors.initials: K
authors.lastname: Herrmann
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D002794:Choline / Q000031:analogs & derivatives; D055088:Early Detection of Cancer / Q000379:methods; D004492:Edetic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D019317:Evidence-Based Medicine; D005709:Gallium Isotopes; D005710:Gallium Radioisotopes; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D008297:Male; D009842:Oligopeptides / Q000493:pharmacokinetics*; D000072078:Positron Emission Tomography Computed Tomography / Q000379:methods*; D017430:Prostate-Specific Antigen / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: D014408:Biomarkers, Tumor; D005709:Gallium Isotopes; D005710:Gallium Radioisotopes; D009842:Oligopeptides; D019275:Radiopharmaceuticals; C000718244:gallium 68 PSMA-11; C447081:methyl carbon-11 choline; D004492:Edetic Acid; D017430:Prostate-Specific Antigen; D002794:Choline